推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 日前，在博鰲亞洲論壇“面向未來：中醫(yī)藥的國際化”早餐會上，對于當前中醫(yī)藥海外發(fā)展的機遇和有利條件，國家衛(wèi)計委副主任王國強表示，凝聚著中華文化精髓的中醫(yī)藥必然會隨著中國經(jīng)濟的發(fā)展受到國際關(guān)注，中醫(yī)的模式也與現(xiàn)代醫(yī)學(xué)的自我調(diào)整方向吻合。此外，中國政府高度重視扶持中醫(yī)藥事業(yè)，中醫(yī)藥走向世界已經(jīng)具備了非常有利的條件。
參會專家認為，中醫(yī)藥走向世界最重要的因素在于自身要有信心。近代以來，中醫(yī)藥隨著中國的發(fā)展跌宕起伏，一段時間以來中國落后于西方，這也對中醫(yī)藥走向國際很不利。王國強認為：“應(yīng)該說現(xiàn)代中醫(yī)的落后，是我們的創(chuàng)新不夠，我們運用先進技術(shù)發(fā)展中醫(yī)的力度還不夠。”
中醫(yī)藥走向世界也是為其他各國人民謀福利。外交部前部長李肇星對此表示贊同：“我們有一部值得中國人自豪的、驕傲的中醫(yī)藥歷史，我們不要忘記。在這個基礎(chǔ)上我們要繼續(xù)前進，把中醫(yī)發(fā)展到更高更好的水平，給中國人民乃至世界人民帶來更大的福利，使他們更加健康快樂。”
